| | | |

Gel-Based Mesothelioma Treatment: A Novel Approach to Pleural Mesothelioma

surgeons using gel-based mesothelioma treatment

Swiss scientists are developing a novel gel-based mesothelioma treatment for people with pleural disease. Early studies suggest it may be a safer way to deliver cancer-fighting drugs with fewer side effects.

The gel-based mesothelioma treatment combines the chemotherapy drug cisplatin with a natural “glue” called fibrin. When the gel is applied during surgery, it can keep fighting tumors for months.

Why Develop a Gel-Based Treatment?

Cisplatin is a platinum-based drug. Together with pemetrexed (Alimta), it is one of the most common chemotherapy drugs for mesothelioma.

In the past decade, doctors came up with a way to increase the effectiveness of cisplatin in people with peritoneal mesothelioma. These patients get chemotherapy the usual way. But they also get a rinse of a heated chemotherapy solution through the abdomen after surgery. The aim is to kill any remaining cancer cells.

The approach has increased peritoneal mesothelioma survival. But it is does not work as well as gel-based mesothelioma treatment for people with pleural mesothelioma.

While the rinse approach does help keep pleural tumors from growing back, it also tends to cause kidney failure. The Swiss team says it may be because pleural mesothelioma patients absorb too much cisplatin, too fast.

The gel-based mesothelioma treatment may offer a way to get around the problem.

Cisplatin + Fibrin = Pleural Mesothelioma Solution

Cisplatin is one component of the new gel-based mesothelioma treatment. The other is fibrin. Fibrin is a protein involved in the clotting of blood. The Swiss researchers refer to it as a natural “glue”.

The researchers got fibrin from fresh frozen blood plasma. They used the fibrin as a carrier for cisplatin. Then they sprayed the gel-based mesothelioma treatment onto pleural mesothelioma tumors in animals.

The gel helped the cisplatin stay in place without speeding up absorption. Treatment results were just as good as liquid and the animals did not have as many kidney problems.

The gel-based mesothelioma treatment also produced high concentrations of cisplatin in the chest. Cisplatin levels stayed high up to 70 days after surgery.

Next Steps for New Mesothelioma Treatment

The next step is for doctors to test the gel-based mesothelioma treatment in human patients. About three quarters of the patients have already been treated in the INFLuenCe-Meso II trial. The trial will test safety and tolerability.

“The study will also allow us to gather information about the clinical efficacy of the treatment,” explain Professor Isabelle Optiz and Dr. Michaela Kirschner. Both researchers work at The Lung and Thoracic Oncology Centre at the University Hospital Zurich.

Opitz and Kirschner are also testing the gel-based mesothelioma treatment again in animals. This time they want to see if the gel could complement radiation therapy.

Source:

“Malignant pleural mesothelioma: from bedside to bench and from bench to bedside”, May 29, 2019, Scitech Europa, https://www.scitecheuropa.eu/malignant-pleural-mesothelioma/95405/

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…